mercredi 30 novembre 2022

Headline: Alzheimer's drug lecanemab hailed as momentous breakthrough

https://www.bbc.co.uk/news/health-63749586

What a nice piece of positive news -
Quote:

One of the world's leading researchers behind the whole idea of targeting amyloid 30 years ago, Prof John Hardy, said it was "historic" and was optimistic "we're seeing the beginning of Alzheimer's therapies". Prof Tara Spires-Jones, from the University of Edinburgh, said the results were "a big deal because we've had a 100% failure rate for a long time".
...snip....

Lecanemab is an antibody - like those the body makes to attack viruses or bacteria - that has been engineered to tell the immune system to clear amyloid from the brain.

Amyloid is a protein that clumps together in the spaces between neurons in the brain and forms distinctive plaques that are one of the hallmarks of Alzheimer's.

...snip...
I'm sure most of us older folk will know of family or friends that have been struck down by Alzheimer's. Hopefully this will only be the start of effective treatments.


Aucun commentaire:

Enregistrer un commentaire